semaglutide and fatty liver 🧬 New Option for Disease The TGA has provisionally approved Wegovy (semaglutide) for adults with MASH moderate to advanced liver fibrosis. ✓ Early intervention is key ✓ Many patients Frontiers | Semaglutide ameliorates metabolism

In our lab, we mostly look at opioid use disorder

Protocol: Creatine: 5g daily Protein: 1.6g per kg body weight (the higher end is critical for recomp) Resistance training: 3-4x per week, progressive overload, full-body or upper/lower split Tracking: DEXA scans every 8-12 weeks, strength progression logs Duration: Ongoing Creatine provides the performance edge that makes progressive overload possible even in a deficit

data curation, R.C.V

The impact of semaglutide on metabolic and cardiovascular risk factors: A systematic review and meta-analysis

Additionally, GSH alone and in combination with amikacin fostered human fibroblast cell (HFF-1) growth and confluence while inhibiting MRAB adhesion and colonization